AbCellera Biologics Inc. ABCL Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- AbCellera Biologics Inc. (ABCL) reported comprehensive income (loss), net of tax, attributable to parent of -$41.35M in Q1 2026.
- How has AbCellera Biologics Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- AbCellera Biologics Inc.'s comprehensive income (loss), net of tax, attributable to parent increased by 14.3% year-over-year, from -$48.24M to -$41.35M.
- What is the long-term trend for AbCellera Biologics Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 3 years (2021 to 2025), AbCellera Biologics Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a -1.6% compound annual growth rate (CAGR), from $153.75M to -$146.27M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This represents the total change in equity during a period resulting from transactions and other events from non-owner sources, including net income and other comprehensive income items. It provides a more holistic view of financial performance by including unrealized gains or losses that are excluded from standard net income. Investors use this to evaluate the total economic impact of all financial activities on shareholder value.